J. Baharani

Injectable Lipid-Lowering Therapies Across the Chronic Kidney Disease Spectrum: Evidence, Safety, and a Stage-Specific Clinical Framework

A stage-specific framework for integrating injectable therapies into CKD pathways is proposed—covering patient selection, sequencing, monitoring and implementation—and outline priorities for CKD-enriched outcome trials, kidney-relevant endpoints, and the integration of emerging lipoprotein(a)-targeted injectables into...